CSF IN THE DIFFERENTIAL DIAGNOSIS OF ALZHEIMER'S DISEASE: CLINICAL UTILITY OF AN EXTENDED PANEL OF BIOMARKERS IN A SPECIALIST COGNITIVE CLINIC